跳至主要内容
临床试验/NCT06826690
NCT06826690已完成4 期

A Comparative Factorial Study Design of Adjuvant Enhanced Ultrasound-Guided Wrist Block Anaesthesia for Hand Surgery : Bupivacane, Dexamethasone, Dexametmiodine

Mahmoud Rafaat Mohamed2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2025年3月30日最近更新:
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
160
试验地点
2
主要终点
Comparing the effectiveness of bupivacane alone and bupivacane with dexamethasone and bupivacane with dexametmiodine and bupivacane with dexamethasone and dexametmiodine

研究概览

简要总结

Ultrasound guided wrist block comparing effect of bupivacane alone and bupivacane with dexamethasone and bupivacane with dexametmiodine and bupivacane with dexamethasone and dexametmiodine

详细描述

Ultrasound guided wrist block comparing effect of bupivacane alone and bupivacane with dexamethasone and bupivacane with dexametmiodine and bupivacane with dexametmiodine and dexamethasone.

Taking medical and surgical history from patients. Taking base line data as heart rate and blood pressure and spo2. Measure duration of analgesia for post operative pain using NRS for 24 hours abd recording NRS at time interval of 2 , 4,6,12,24 hours post operative.

Any patient the NRS above 4 will receive 5 mg nalbufin . Recording patients satisfaction by a survey .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Patients more than or equal 18 years old and are ASA 1-3

排除标准

  • allergy to used medication
  • pre exist neuropathy
  • coagulapthy
  • cognitive impairment
  • refusal to participate
  • Failed block and requiring general anesthesia

研究组 & 干预措施

Group2: ultrasound guided wrist block with bupivacane.25% and 8mg dexamethasone

Active Comparator

Group 2: 40 patients receive ultrasound guided wrist block with 15 ml volume including bupivacane.25% and 8 mg dexamethasone

干预措施: Group 3: ultrasound guided wrist block with bupivacane and dexametmiodine (Procedure)

Group2: ultrasound guided wrist block with bupivacane.25% and 8mg dexamethasone

Active Comparator

Group 2: 40 patients receive ultrasound guided wrist block with 15 ml volume including bupivacane.25% and 8 mg dexamethasone

干预措施: Group 4: patients will receive ultrasound guided wrist block with bupivacane and dexamethasone and dexametmiodine (Procedure)

Group 3: ultrasound guided wrist block with bupivacane and dexametmiodine

Active Comparator

Group 3: 40 patients receive ultrasound guided wrist block with 15 ml volume totally including bupivacane.25% and 50 mcg dexametmiodine

干预措施: Group 2 : ultrasound guided wrist block with bupivacane and dexamethasone (Procedure)

Group 3: ultrasound guided wrist block with bupivacane and dexametmiodine

Active Comparator

Group 3: 40 patients receive ultrasound guided wrist block with 15 ml volume totally including bupivacane.25% and 50 mcg dexametmiodine

干预措施: Group 3: ultrasound guided wrist block with bupivacane and dexametmiodine (Procedure)

Group 4: ultrasound guided wrist block with bupivacane and dexametmiodine and dexamethasone

Active Comparator

Group 4 : 40 patients receive ultrasound guided wrist block with 15 ml volume including bupivacane.25% and 8 mg dexamethasone and 50 mcg dexametmiodine

干预措施: Group 3: ultrasound guided wrist block with bupivacane and dexametmiodine (Procedure)

Group 4: ultrasound guided wrist block with bupivacane and dexametmiodine and dexamethasone

Active Comparator

Group 4 : 40 patients receive ultrasound guided wrist block with 15 ml volume including bupivacane.25% and 8 mg dexamethasone and 50 mcg dexametmiodine

干预措施: Group 1: ultrasound guided wrist block with bupivacane alone (Procedure)

Group 4: ultrasound guided wrist block with bupivacane and dexametmiodine and dexamethasone

Active Comparator

Group 4 : 40 patients receive ultrasound guided wrist block with 15 ml volume including bupivacane.25% and 8 mg dexamethasone and 50 mcg dexametmiodine

干预措施: Group 4: patients will receive ultrasound guided wrist block with bupivacane and dexamethasone and dexametmiodine (Procedure)

Group 3: ultrasound guided wrist block with bupivacane and dexametmiodine

Active Comparator

Group 3: 40 patients receive ultrasound guided wrist block with 15 ml volume totally including bupivacane.25% and 50 mcg dexametmiodine

干预措施: Group 1: ultrasound guided wrist block with bupivacane alone (Procedure)

Group 1: ultrasound guided wrist block with bupivacane alone

Active Comparator

Group 1: ultrasound guided wrist block with bupivacane.025% .. 15 ml volume totally

干预措施: Group 1: ultrasound guided wrist block with bupivacane alone (Procedure)

Group 1: ultrasound guided wrist block with bupivacane alone

Active Comparator

Group 1: ultrasound guided wrist block with bupivacane.025% .. 15 ml volume totally

干预措施: Group 2 : ultrasound guided wrist block with bupivacane and dexamethasone (Procedure)

Group 1: ultrasound guided wrist block with bupivacane alone

Active Comparator

Group 1: ultrasound guided wrist block with bupivacane.025% .. 15 ml volume totally

干预措施: Group 3: ultrasound guided wrist block with bupivacane and dexametmiodine (Procedure)

Group 1: ultrasound guided wrist block with bupivacane alone

Active Comparator

Group 1: ultrasound guided wrist block with bupivacane.025% .. 15 ml volume totally

干预措施: Group 4: patients will receive ultrasound guided wrist block with bupivacane and dexamethasone and dexametmiodine (Procedure)

Group2: ultrasound guided wrist block with bupivacane.25% and 8mg dexamethasone

Active Comparator

Group 2: 40 patients receive ultrasound guided wrist block with 15 ml volume including bupivacane.25% and 8 mg dexamethasone

干预措施: Group 1: ultrasound guided wrist block with bupivacane alone (Procedure)

Group2: ultrasound guided wrist block with bupivacane.25% and 8mg dexamethasone

Active Comparator

Group 2: 40 patients receive ultrasound guided wrist block with 15 ml volume including bupivacane.25% and 8 mg dexamethasone

干预措施: Group 2 : ultrasound guided wrist block with bupivacane and dexamethasone (Procedure)

Group 3: ultrasound guided wrist block with bupivacane and dexametmiodine

Active Comparator

Group 3: 40 patients receive ultrasound guided wrist block with 15 ml volume totally including bupivacane.25% and 50 mcg dexametmiodine

干预措施: Group 4: patients will receive ultrasound guided wrist block with bupivacane and dexamethasone and dexametmiodine (Procedure)

Group 4: ultrasound guided wrist block with bupivacane and dexametmiodine and dexamethasone

Active Comparator

Group 4 : 40 patients receive ultrasound guided wrist block with 15 ml volume including bupivacane.25% and 8 mg dexamethasone and 50 mcg dexametmiodine

干预措施: Group 2 : ultrasound guided wrist block with bupivacane and dexamethasone (Procedure)

结局指标

主要结局

Comparing the effectiveness of bupivacane alone and bupivacane with dexamethasone and bupivacane with dexametmiodine and bupivacane with dexamethasone and dexametmiodine

时间窗: 24 hour

Comparing duration of analgesia by each combination from block administration to first request of analgesia

dexamethasone × dexmedetomidine interaction on duration of postoperative analgesia, defined as the time from completion of the block to the first request for rescue analgesia.

时间窗: defined as the time from block administration to first request of analgesia during the first 24 hour

defined as the time from block administration to first request of analgesia

次要结局

未报告次要终点

研究者

发起方
Mahmoud Rafaat Mohamed
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mahmoud Rafaat Mohamed

Resident doctor

Aswan University

研究点 (2)

Loading locations...

相似试验